What is Hemlibra?

Hemlibra (Emicizumab) is a subcutaneous injection and treatment for patients concerning Hemophilia A. It was developed by Genentech and Chugai and was approved in the United States in November of 2017.

Hemlibra can be injected on one's own in the lower abdomen, thighs, or only by a caregiver, in one's upper arms. How to inject Hemlibra: https://www.hemlibra.com/patient/taking-hemlibra/injecting-hemlibra.html

Learn more about Hemlibra at https://www.hemlibra.com/patient.html